Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 14/20 | 0.49 |
| ▸ | MAPKAPK5 | Q8IW41 | 2/20 | 0.44 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.39 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.39 |
| ▸ | PKN2 | Q16513 | 2/20 | 0.39 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.39 |
| ▸ | SLK | Q9H2G2 | 2/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | INSR | P06213 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | LYN | P07948 | 1/20 | 0.39 |
| ▸ | RET | P07949 | 1/20 | 0.39 |
| ▸ | ROS1 | P08922 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | FER | P16591 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | BLK | P51451 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25173403 | 0.92 | SYK (0.41) | SYKMAPKAPK5PTK6AURKB | |
| SCHEMBL25170422 | 0.92 | SYK (0.41) | SYKMAPKAPK5PTK6AURKB | |
| SCHEMBL30385514 | 0.92 | SYK (0.40) | SYKMAPKAPK5PTK6AURKB | |
| Hydrochloric Acid SCHEMBL30385672 | 0.92 | SYK (0.40) | SYKMAPKAPK5PTK6AURKB | |
| SCHEMBL30171980 | 0.91 | TTK (0.41) | SYKPTK6KCNH2 | |
| SCHEMBL22123172 | 0.91 | TTK (0.41) | SYKPTK6KCNH2 | |
| SCHEMBL22139113 | 0.91 | PTK6 (0.48) | SYKMAPKAPK5PTK6MAP4K4MAP4K2 | |
| SCHEMBL30172107 | 0.91 | PTK6 (0.48) | SYKMAPKAPK5PTK6MAP4K4MAP4K2 | |
| SCHEMBL22124340 | 0.90 | CDK2 (0.44) | SYKMAPKAPK5PTK6AURKBAURKA | |
| SCHEMBL24940106 | 0.90 | SYK (0.44) | SYKMAPKAPK5PTK6PDE4BMAP4K4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898631-B1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | HOFFMANN LA ROCHE (CH) | 2023-01-18 | — | — | EP | disclosed |
| US-20230012368-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012368-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | MRPL21, MYD88, IL1R1 | SYK 954/4885MAPKAPK5 647/4885PTK6 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.